O
MDSO

OppenheimerFunds’s Medidata Solutions, Inc. MDSO Stock Holding History

OppenheimerFunds’s Portfolio MDSO Stock Details MDSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-3,418
Closed -$217K – 1862
2017
Q4 		$217K Sell
3,418
-205,384
-98% -$14.6M ﹤0.01% 1793
2017
Q3 		$16.3M Buy
208,802
+24,109
+13% +$1.84M 0.02% 638
2017
Q2 		$14.4M Buy
184,693
+177,830
+2,591% +$12.4M 0.02% 657
2017
Q1 		$396K Buy
6,863
+1,517
+28% +$82K ﹤0.01% 1602
2016
Q4 		$266K Buy
5,346
+1,686
+46% +$87.5K ﹤0.01% 1652
2016
Q3 		$204K Buy
+3,660
New +$194K ﹤0.01% 1649
2016
Q1 		– Sell
-4,361
Closed -$215K – 1756
2015
Q4 		$215K Buy
+4,361
New +$192K ﹤0.01% 1641
2014
Q2 		– Sell
-367,354
Closed -$20M – 989
2014
Q1 		$20M Sell
367,354
-80,580
-18% -$4.91M 0.02% 572
2013
Q4 		$27.1M Sell
447,934
-164,360
-27% -$9.11M 0.03% 495
2013
Q3 		$30.3M Buy
612,294
+35,120
+6% +$1.55M 0.04% 431
2013
Q2 		$22.4M Buy
+577,174
New +$18.8M 0.03% 488

Other funds holding MDSO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

OppenheimerFunds's MDSO Position: Q1 2018 in Review

OppenheimerFunds sold out of Medidata Solutions, Inc. (MDSO) in Q1 2018, closing a stake of 3,418 shares — an estimated $217K sold.

OppenheimerFunds first reported a position in MDSO in Q2 2013 and held it in 11 quarters. The position peaked at $30.3M in Q3 2013. 256 funds tracked by Wall St. Rank hold MDSO as of Q1 2018.

  • OppenheimerFunds reported no remaining Medidata Solutions, Inc. position as of Q1 2018 after selling out during the quarter.
  • OppenheimerFunds sold 3,418 Medidata Solutions, Inc. shares in Q1 2018, an estimated $217K.
  • OppenheimerFunds first reported a position in Medidata Solutions, Inc. in Q2 2013 and held it in 11 quarters.
  • OppenheimerFunds's Medidata Solutions, Inc. position peaked at $30.3M in Q3 2013.
  • 256 funds tracked by Wall St. Rank held Medidata Solutions, Inc. as of Q1 2018.

Based on OppenheimerFunds's 13F filing for Q1 2018, filed 11 May 2018.